With over USD 1 billion in capital investment, and a rich intellectual property portfolio
Over the years, extensive research in the field of flow cytometry has enabled the development of a variety of novel technologies that are capable of efficiently isolating rare cells from heterogenous cell populations.
By: Roots Analysis
Roots Analysis has announced the addition of the "Novel Cell Sorting and Separation Market: Focus on Acoustophoresis, Buoyancy-activated, Dielectrophoresis, Magnetophoretics, Microfluidics, Optoelectronics, Traceless Affinity and Other Technologies, 2019-2030" report to its list of offerings.
Over the years, extensive research in the field of flow cytometry has enabled the development of a variety of novel technologies that are capable of efficiently isolating rare cells from heterogenous cell populations. These innovative solutions are compatible for use across a myriad of application areas and coupled to the ongoing innovation in this domain, are likely to translate into lucrative future opportunity for stakeholders.
To order this 500+ page report, which features 290+ figures and 350+ tables, please visit this link (https://www.rootsanalysis.com/
Key Market Insights
More than 200+ innovative cell sorters, isolation kits and affiliated consumables currently available in the market
Cell sorters, based on innovative cell separation approaches and novel technologies, account for more than 45% of the total number of cell sorting products currently available in the market. Examples of innovative cell sorters include AcouTrap, C1™ System, Cytonome Viva™, LeviCell System, LumiSort™, Namo™ Single Cell Dispenser, Radiance™, Sefia S-1000, WOLF® Cell Sorter, and X-BACS™.
Stakeholders claim that such products provide the most suitable micro-fabricated channels that actually allow for faster detection of single cells. Other advanced cell sorting principles include magnetophoretics, optoelectronics, buoyancy-activated, and acoustofluidics.
Currently, the major application areas of cell isolation technologies is genomic analysis and cancer diagnostics
More than 65% of the companies are presently developing products and solutions for use in genomics and transcriptomics-
3,000+ patents have been filed / granted since 2014
Since 2014, more than 500 patents have been filed / granted each year across the globe, with close to 850 patents in 2018, alone. It is worth highlighting that around 60% of the patents were filed / granted in the US.
+1 (415) 800 3415
+44 (122) 391 1091